Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Soleus Capital Master Fund, L.P.'s stake in Praxis Precision Medicines, Inc. fell to 4.60% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 5, 2025
Soleus Capital Master Fund, L.P.'s stake in Praxis Precision Medicines, Inc. fell to 4.60%, 966,740 shares, as a passive investor on Jun 30, 2025. Filed Aug 5, 2025 (Schedule 13G/A).
- Stake
- 4.60%
- Shares
- 966,740
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 4.60% | 966,740 |
| Soleus Capital, LLC | 4.60% | 966,740 |
| Soleus Capital Group, LLC | 4.60% | 966,740 |
| Soleus Capital Management, L.P. | 4.60% | 966,740 |
| Soleus GP, LLC | 4.60% | 966,740 |
| Guy Levy | 4.60% | 966,740 |
Source
Related
- Praxis Precision Medicines, Inc.
- Soleus Capital Master Fund, L.P.
- Praxis Precision Medicines, Inc. shareholders
- Schedule 13G · Soleus Capital Master Fund, L.P. · Mar 19, 2025
- Schedule 13G/A · Orbis Investment Management LTD · Aug 14, 2026
- Form 4 · Souza Marcio · Jul 8, 2026
- Form 4 · DeSimone Jill · Jun 26, 2026
- Form 4 · Arbuckle Stuart A · Jun 12, 2026
- Form 4 · Chodakewitz Jeffrey · Jun 12, 2026